Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ANAB | ANAPTYSBIO INC | FRAZIER ALAN D | 10% Owner | Feb 02, 2017 | Option Exercise | $4.55 | 117,235 | 533,419 | 2,345,612 | Feb 06, 2017, 05:14 PM | |
ANAB | ANAPTYSBIO INC | FRAZIER ALAN D | 10% Owner | Feb 02, 2017 | Option Exercise | $4.55 | 117,235 | 533,419 | 2,345,612 | Feb 06, 2017, 05:14 PM | |
ANAB | ANAPTYSBIO INC | FRAZIER ALAN D | 10% Owner | Jan 31, 2017 | Buy | $15.00 | 311,291 | 4,669,365 | 311,291 | Jan 31, 2017, 04:20 PM | |
ANAB | ANAPTYSBIO INC | FRAZIER ALAN D | 10% Owner | Jan 31, 2017 | Buy | $15.00 | 88,709 | 1,330,635 | 88,709 | Jan 31, 2017, 04:20 PM | |
ANAB | ANAPTYSBIO INC | FRAZIER ALAN D | 10% Owner | Jan 31, 2017 | Buy | $15.00 | 400,000 | 6,000,000 | 311,291 | Jan 31, 2017, 04:16 PM | |
CADX | CADENCE PHARMACEUTICALS INC | FRAZIER ALAN D | Director | Mar 19, 2014 | Option Exercise | $14.00 | 4,796,711 | 67,153,954 | 0 | Mar 21, 2014, 01:43 PM | |
CADX | CADENCE PHARMACEUTICALS INC | FRAZIER ALAN D | Director | Mar 19, 2014 | Option Exercise | $14.00 | 3,816,474 | 53,430,636 | 0 | Mar 21, 2014, 01:43 PM | |
CADX | CADENCE PHARMACEUTICALS INC | FRAZIER ALAN D | Director | Feb 12, 2014 | Option Exercise | $10.05 | 271,116 | 2,725,065 | 4,894,035 | Feb 21, 2014, 05:11 PM | |
CADX | CADENCE PHARMACEUTICALS INC | FRAZIER ALAN D | Director | Feb 12, 2014 | Option Exercise | $10.05 | 2,440,042 | 24,525,554 | 4,692,387 | Feb 21, 2014, 05:11 PM |